Forxiga Archives -

In November, NICE backed NHS use of AstraZeneca’s diabetes and heart failure drug Forxiga for the treatment of

Chronic kidney disease: treating a silent killer

https://pharmaphorum.com/patients/chronic-kidney-disease-treating-a-silent-killer/

Tens of thousands of people with chronic kidney disease in England could be eligible for treatment with AstraZeneca’s

Cautious welcome as NICE backs Forxiga for chronic kidney disease

https://pharmaphorum.com/news/cautious-welcome-as-nice-backs-forxiga-for-chronic-kidney-disease/

AstraZeneca’s Forxiga has become the first SGLT2 inhibitor to be approved in Europe for use in people with

AZ gets European approvals for Forxiga in chronic kidney disease

https://pharmaphorum.com/news/az-gets-european-approvals-for-forxiga-in-chronic-kidney-disease/

AstraZeneca’s fast-growing SGLT2 inhibitor Forxiga could soon get a further boost from approval in the EU as a

AZ closes in Forxiga kidney disease label in EU after nod from CHMP

https://pharmaphorum.com/news/az-closes-in-forxiga-kidney-disease-label-in-eu-after-nod-from-chmp/

Just a few weeks after its EU approval for heart failure, AstraZeneca’s Forxiga has been backed by NICE

NICE backs AZ’s Forxiga for heart failure

https://pharmaphorum.com/news/nice-backs-azs-forxiga-for-heart-failure/

AstraZeneca has been cleared to include cardiovascular and kidney outcomes data on the label of its type 2

AZ’s Forxiga gets heart claim data on its EU label

https://pharmaphorum.com/news/azs-forxiga-gets-heart-claim-data-on-its-eu-label/

GlaxoSmithKline raised eyebrows last year when it paid $5.1 billion for Tesaro and its PARP inhibitor Zejula, amid

Relief for GSK as Tesaro’s Zejula hits the mark in ovarian cancer

https://pharmaphorum.com/news/relief-for-gsk-as-tesaros-zejula-hits-the-mark-in-ovarian-cancer/

AstraZeneca and Bristol-Myers Squibb have received a positive opinion from an FDA committee for dapagliflozin, a sodium-glucose cotransporter

First-in-class diabetes drug recommended for FDA approval

https://pharmaphorum.com/news/first-in-class-diabetes-drug-recommended-for-fda-approval/

Forxiga